middle.news
Pathkey.AI Lands A$100K Deal to Power Imunexus Clinical Trials
9:44am on Thursday 2nd of April, 2026 AEDT
•
Technology
Read Story
Pathkey.AI Lands A$100K Deal to Power Imunexus Clinical Trials
9:44am on Thursday 2nd of April, 2026 AEDT
Key Points
A$100,000+ GST contract with Imunexus Therapeutics
TrialKey platform applied to clinical trial optimisation and capital raising support
Initial payment plus milestone-based fees contingent on Imunexus capital raises
Contract term of one year with potential for expanded future engagements
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
Pathkey.Ai (ASX:PKY)
OPEN ARTICLE